Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The relevance of molecular genotyping to allocate cases in a suspected outbreak of Legionella pneumonia in patients with prolonged immunosuppressive therapy.
Borella P, Vecchi E, Incerti F, Marchesi I, Meacci M, Frezza G, Fregni Serpini G, Mansi A, Paduano S, Bargellini A. Borella P, et al. Among authors: frezza g. Int J Infect Dis. 2020 Feb;91:174-176. doi: 10.1016/j.ijid.2019.11.002. Epub 2019 Nov 7. Int J Infect Dis. 2020. PMID: 31707135 Free article.
In praise of serendipity.
Kneebone R, Frezza G. Kneebone R, et al. Among authors: frezza g. Lancet. 2024 Apr 6;403(10434):1330-1331. doi: 10.1016/S0140-6736(24)00644-5. Lancet. 2024. PMID: 38583448 No abstract available.
Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy.
Paduano S, Granata M, Turchi S, Modenese A, Galante P, Poggi A, Marchesi I, Frezza G, Dervishaj G, Vivoli R, Verri S, Marchetti S, Gobba F, Bargellini A. Paduano S, et al. Among authors: frezza g. Antibodies (Basel). 2023 Dec 1;12(4):77. doi: 10.3390/antib12040077. Antibodies (Basel). 2023. PMID: 38131799 Free PMC article.
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial.
Meduri B, Baldissera A, Iotti C, Scheijmans LJEE, Stam MR, Parisi S, Boersma LJ, Ammendolia I, Koiter E, Valli M, Scandolaro L, Busz D, Stenfert Kroese MC, Ciabatti S, Giacobazzi P, Ruggieri MP, Engelen A, Munafò T, Westenberg AH, Verhoeven K, Vicini R, D'Amico R, Lohr F, Bertoni F, Poortmans P, Frezza GP. Meduri B, et al. Among authors: frezza gp. J Clin Oncol. 2023 Apr 20;41(12):2201-2210. doi: 10.1200/JCO.22.01485. Epub 2023 Jan 9. J Clin Oncol. 2023. PMID: 36623246 Clinical Trial.
119 results